NCT04253080View on ClinicalTrials.gov

Expression of IL4 Induced Gene 1 in Patients With Cutaneous Melanoma: Value in Prognosis and/or in Predictive Response to Immune Checkpoint Inhibitors

NARecruitingINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

April 12, 2022

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
Cutaneous Melanoma
Interventions
BIOLOGICAL

Blood sample

Blood sample before treatment, 3 months after treatment and after 1 year or relapse or resumption of disease progression.

BIOLOGICAL

Cutaneous melanoma biopsy

Cutaneous melanoma biopsy before treatment, 3 months after treatment and relapse or resumption of disease progression.

Trial Locations (1)

75014

RECRUITING

Dermatology department, Paris

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

collaborator

Association Robert Debré (ARD)

UNKNOWN

collaborator

Société de Dermatologie Française

OTHER

collaborator

Institut Cochin

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER